Phase 2 Readout
GPCR: Phase 2 Readout: aleniglipron
December 31, 2026 · aleniglipron. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- December 31, 2026
- Company
- Structure Therapeutics Inc. (GPCR)
- Drug
- aleniglipron
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: aleniglipron
- Drug
- aleniglipron
- Indication
- obesity or overweight and type 2 diabetes mellitus